Erban J, Homolka J
Oddĕlení TRN, Praha, a Ustav fyziologie I. LF UK, Praha.
Cas Lek Cesk. 1996 Oct 9;135(19):617-9.
Long-term domiciliary oxygen therapy was introduced in the Czech Republic as a standard therapeutic method in patients with chronic respiratory failure in October 1992. As a source of oxygen almost exclusively oxygen concentrators are used which are allocated to the patients according to criteria elaborated by the European Respiratory Society.
From October 1, 1992 to October 1, 1995 the mean number of installed concentrators is 10,24/100000 population. From a total of 1064 patients by October 1, 1995 3.8% were treated for three years, 20.7% for two years and 34.4% for more than one year. In the course of three years a total of 490 patients died. The mean survival period of patients treated for prolonged periods by domiciliary oxygen therapy was 8.88 months. The high mortality rate is due to the fact that patients in a very serious state are treated. On account of chronic pulmonary disease oxygen therapy was indicated in 93.4%, on account of interstitial pulmonary processes (KFA and other fibroses) in 3.9, on account of kyphoscoliosis in 2.4% and on account of cystic fibrosis in 0.3% of the group. The mean costs of treatment were 114.40 Kĕ/day which is a third of the costs when the patient is hospitalized.
Domiciliary oxygen therapy proved effective and economical in patients with chronic respiratory failure.
1992年10月,长期家庭氧疗在捷克共和国被引入,作为慢性呼吸衰竭患者的标准治疗方法。几乎仅使用氧气浓缩器作为氧气来源,这些氧气浓缩器根据欧洲呼吸学会制定的标准分配给患者。
1992年10月1日至1995年10月1日,平均每10万人口中安装的氧气浓缩器数量为10.24台。到1995年10月1日,在总共1064例患者中,3.8%接受了三年治疗,20.7%接受了两年治疗,34.4%接受了一年以上治疗。在三年期间,共有490例患者死亡。接受长期家庭氧疗的患者平均生存期为8.88个月。高死亡率是由于治疗的患者病情非常严重。在该组患者中,因慢性肺部疾病接受氧疗的占93.4%,因间质性肺部疾病(KFA和其他纤维化)接受氧疗的占3.9%,因脊柱侧凸接受氧疗的占2.4%,因囊性纤维化接受氧疗的占0.3%。治疗的平均费用为每天114.40捷克克朗,这是患者住院时费用的三分之一。
家庭氧疗对慢性呼吸衰竭患者被证明是有效且经济的。